Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Epilepsy × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Myelodysplastic Syndromes 13 Lymphoma, Non-Hodgkin 13 Leukemia, Myeloid, Acute 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Mantle-Cell 12 Hodgkin Disease 12 Multiple Myeloma 10 Lymphoma 10 Leukemia 10 Sarcoma 9 Lymphoma, Large B-Cell, Diffuse 9 Graft vs Host Disease 9 Burkitt Lymphoma 9 Waldenstrom Macroglobulinemia 8 Myeloproliferative Disorders 8 Lymphoma, Follicular 8 Lymphoma, B-Cell, Marginal Zone 8 Tuberous Sclerosis 6 Primary Myelofibrosis 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6 Congenital Abnormalities 6 Breast Neoplasms 6 Lymphoma, Large-Cell, Anaplastic 5 Lymphangioleiomyomatosis 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5 Leukemia, Myeloid, Accelerated Phase 5

Interventions

Everolimus 2 perampanel 1 clevidipine 1 Sirolimus 1 Sevoflurane 1 Propofol 1 Nitrous Oxide 1 Lidocaine 1 Immunoglobulins, Intravenous 1 Glycopyrrolate 1 Dexmedetomidine 1 Anticonvulsants 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04595513 2024-05-16

STOP2

Children's Hospital Medical Center, Cincinnati

Phase 1/2 Completed

5 enrolled 15 charts

Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡